🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

How to pick a problem. Today in Cell. 1/53 cell.com/cell/fulltext/…

Join our virtual immunology symposium Scripps Research on Wed, Sept 18 featuring Zuri Sullivan, Alex Wells, Djenet Bousbaine, Dr. Valeria M. Reyes Ruiz, Maria Cecilia Canesso, Dr. Delconte, Liwen Deng, & Nagela Ghabdan Zanluqui. Register: bit.ly/ScrippsLeaders

Check this out! Beautiful work out of the Sattely_lab sattelylab.bsky.social by Conor McClune revealing the genes involved in taxol production. Great to see it out after watching the story unfold throughout the years.

Beautiful work from Djenet Bousbaine and Michael Fischbach characterizing the immune response to a human skin commensal and its utility as a vaccination platform. Remarkable antibody response kinetics worthy of an entirely new study.

Check out this bombshell publication by Michael Fischbach and coworkers Sarafan ChEM-H Stanford Engineering Stanford Medicine, imagine a cancer immune therapy/vaccine where treatment begins and ends with a painless topical skin treatment! 🤯

discovery that a skin microbe can, without inflammation, induce a systemic B-cell response... and then engineering that microbe into a potent vaccine platform that can be applied as a topical cream. amazing work from Djenet Bousbaine and Michael Fischbach ! nature.com/articles/s4158…

New work from Michael Fischbach lab! It was such an honor to work with the insanely talented Djenet Bousbaine and so fun to see it all come together here!

Beautiful work with Djenet Bousbaine Kate Bauman Michael Fischbach Belkaid Lab - skin commensal colonization generates re-directable and potent antibody responses!

Engineered skin S. epidermidis unleashes a potent antibody and T cell response against encoded pathogenic epitopes as a novel topical vaccine that could be applied in a cream Michael Fischbach Belkaid Lab Djenet Bousbaine nature nature.com/articles/s4158… nature.com/articles/s4158…

.Djenet Bousbaine and team (h/t Michael Fischbach) found that an engineered skin bacterium, swabbed gently on the head of a mouse, can unleash a potent antibody response against a pathogen. Could lead to topical vaccines that are applied in a cream. nature.com/articles/s4158…

What an amazing story that was such a blast to collaborate on with Michael Fischbach lab!!! Phenomenal work led by Djenet Bousbaine and all co-authors!! Unroll this thread and be amazed 🤯👇🏾

So thankful to work with you!

It's clear that many do not understand what NIH-funded research does to improve health. It's time to revive a study published 10 years ago that provides incredible information about this. link in the comment Every single new drug approved by the FDA from 2010–2016 was built on

Please check out this beautiful work out of the Sattely lab completing the taxol pathway!

It’s truly an honor to receive this year’s Science Magazine Noster Microbiome prize. Here’s my essay on how we can engineer skin microbes to build vaccines:

The Blum lab is recruiting graduate students and postdocs to work on projects focused on food allergy and oral tolerance! Join our new group at the Salk Institute! Grad students: Reach out to me if you're interested in a rotation! Postdoc candidates: recruiting2.ultipro.com/SAL1013SIBS/Jo…